JCR Pharmaceuticals Co., Ltd.
JCR Pharmaceuticals Co., Ltd. (JPX: 4552) is trading at ¥503.00, about ₹307 at today's JPY/INR rate, as of 30 Sep 2026, 2:09 AM ET, up 1.21% today. Indian residents can buy JCR Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
¥491.00
Today's high
¥507.00
52 week low
¥444.00
52 week high
¥824.00
4552 opened at ¥500.00, closed previously at ¥497.00, and has traded between ¥444.00 and ¥824.00 over the past 52 weeks.
About
JCR Pharmaceuticals Co., Ltd. is a specialized pharmaceutical firm primarily engaged in the creation, development, manufacturing, international trade, and distribution of medicinal products, regenerative therapies, and active pharmaceutical ingredients within Japan. The company offers a range of therapeutic solutions, including GROWJECT, which addresses growth hormone deficiency and short stature; IZCARGO, prescribed for Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion, utilized in the management of Fabry disease; and TEMCELL HS Inj, employed to treat acute graft-versus-host disease. Beyond its current offerings, JCR Pharmaceuticals is also developing Epoetin Alfa BS and Darbepoetin Alfa BS Injections, both intended for the treatment of renal anemia. Furthermore, the company markets various medical devices and laboratory instruments. Founded in 1975, its headquarters are situated in Ashiya, Japan.
Key statistics
Avg. volume
609.43K
Market cap
¥61.37B
P/E Ratio
74.85
Price-to-sales ratio
1.48
Enterprise value
¥109.15B
Free cash flow yield
-16.69%
Debt-to-equity ratio
1.25
Return on equity
4.64%
ROIC
0.29%
Beta
0.42
Dividend yield
3.98%
Last dividend
¥20.00
Financial overview
Revenue
¥40.32B
Earnings per share
¥17.86
Free cash flow
-¥11.56B
Net profit margin
1.97%
Gross margin
75.60%
EBITDA
¥6.18B
Revenue growth
21.91%
Similar securities
This is not an investment recommendation
How to buy JCR Pharmaceuticals from India
Indian residents can buy JCR Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.
Search for JCR Pharmaceuticals and place an order
Find JCR Pharmaceuticals by name or by its ticker, 4552, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. JCR Pharmaceuticals trades 5:30 am – 12:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your JCR Pharmaceuticals position in JPY and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in JCR Pharmaceuticals from India
Trading and taxes when buying JCR Pharmaceuticals from India
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm JST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. JCR Pharmaceuticals’ current yield is 3.98%.Dividend tax explained
- Estate or inheritance tax
- May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy JCR Pharmaceuticals stock?
Yes. JCR Pharmaceuticals (4552) has been listed on the Tokyo Stock Exchange since 2005, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one JCR Pharmaceuticals share cost in rupees?
One JCR Pharmaceuticals share is ¥503.00 — about ₹307 at a JPY/INR rate of 0.6103 on 29 Sep 2026. Both the JCR Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying JCR Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of JCR Pharmaceuticals?
The Tokyo Stock Exchange typically trades in units of 100 shares.
How are gains on JCR Pharmaceuticals shares taxed in India?
Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the JCR Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does JCR Pharmaceuticals pay a dividend, and how is it taxed in India?
Yes. JCR Pharmaceuticals pays a dividend and the current yield is 3.98%; the last declared dividend was ¥20.00 per share, about ₹12.21. Dividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade JCR Pharmaceuticals from India?
The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on JCR Pharmaceuticals shares held from India?
Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.
Do I have to declare JCR Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your JCR Pharmaceuticals holding, its cost and its closing value.
How do I sell JCR Pharmaceuticals and bring the money back to India?
You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.